Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity

Human Primary Breast Cancer Stem Cells Are Characterized by Epithelial-Mesenchymal Plasticity

Triple-negative breast cancer (TNBC) is one of the most aggressive subtypes of breast cancer, with only limited treatment options available. Recently, cancer stem cells (CSCs) have emerged as the potential drivers of tumor progression due to their ability to both self-renew and give rise to differen...

Full description

Bibliographic Details
Main Authors:	Juliane Strietz, Stella S. Stepputtis, Marie Follo, Peter Bronsert, Elmar Stickeler, Jochen Maurer
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	International Journal of Molecular Sciences
Subjects:	triple-negative breast cancer cancer stem cells epithelial-mesenchymal transition epithelial-mesenchymal plasticity
Online Access:	https://www.mdpi.com/1422-0067/22/4/1808

Similar Items

Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial–Mesenchymal Plasticity
by: Barbora Kvokačková, et al.
Published: (2021-05-01)

Communication Between Epithelial–Mesenchymal Plasticity and Cancer Stem Cells: New Insights Into Cancer Progression
by: Xiaobo Zheng, et al.
Published: (2021-04-01)

Cancer spreading patterns based on epithelial-mesenchymal plasticity
by: Rui Wang, et al.
Published: (2024-04-01)

The Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy and the Epithelial–Mesenchymal Transition
by: Stefano Zapperi, et al.
Published: (2023-03-01)

Epithelial-to-Mesenchymal Transition in the Pathogenesis and Therapy of Head and Neck Cancer
by: Julia Thierauf, et al.
Published: (2017-07-01)

The Role of the IL-6 Cytokine Family in Epithelial–Mesenchymal Plasticity in Cancer Progression
by: Andrea Abaurrea, et al.
Published: (2021-08-01)

Role of Epithelial–Mesenchymal Plasticity in Pseudomyxoma Peritonei: Implications for Locoregional Treatments
by: Maria Luisa Calabrò, et al.
Published: (2020-11-01)

Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy
by: Qiu-Luo Liu, et al.
Published: (2021-04-01)

PKCα Modulates Epithelial-to-Mesenchymal Transition and Invasiveness of Breast Cancer Cells Through ZEB1
by: María Candelaria Llorens, et al.
Published: (2019-11-01)

Dual inhibition of Wnt and Yes‐associated protein signaling retards the growth of triple‐negative breast cancer in both mesenchymal and epithelial states
by: Andrew Sulaiman, et al.
Published: (2018-04-01)

Mesenchymal Subtype of Triple-Negative Breast Cancer: A Review of Specific Features
by: Nadezhda V. Krakhmal, et al.
Published: (2023-03-01)

Investigating epithelial‐mesenchymal heterogeneity of tumors and circulating tumor cells with transcriptomic analysis and biophysical modeling
by: Federico Bocci, et al.
Published: (2021-06-01)

Unraveling the Role of Epithelial–Mesenchymal Transition in Adenoid Cystic Carcinoma of the Salivary Glands: A Comprehensive Review
by: Cosima C. Hoch, et al.
Published: (2023-05-01)

Editorial: Epithelial-Mesenchymal Transition: Yet Another Exciting Avenue in Cancer Metabolic Remodeling
by: Katarína Smolková, et al.
Published: (2021-01-01)

NRF2-dependent Epigenetic Regulation can Promote the Hybrid Epithelial/Mesenchymal Phenotype
by: Wen Jia, et al.
Published: (2022-01-01)

Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways
by: Michelle M. Williams, et al.
Published: (2021-11-01)

Epithelial-to-Mesenchymal Transition-Related Markers in Prostate Cancer: From Bench to Bedside
by: Samantha Gogola, et al.
Published: (2023-04-01)

PKMYT1 Promotes Epithelial-Mesenchymal Transition Process in Triple-Negative Breast Cancer by Activating Notch Signaling
by: Bin Li, et al.
Published: (2024-01-01)

Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
by: Yanrong Su, et al.
Published: (2018-12-01)

Tamoxifen reverses epithelial–mesenchymal transition by demethylating miR-200c in triple-negative breast cancer cells
by: Qian Wang, et al.
Published: (2017-07-01)

Expression of mesenchymal–epithelial transition factor in estrogen receptor-negative breast carcinoma
by: Dalia M Abouelfadl, et al.
Published: (2022-01-01)

The Role of <i>SMAD4</i> Inactivation in Epithelial–Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link?
by: Marie-Lucie Racu, et al.
Published: (2022-02-01)

Epithelial-to-Mesenchymal Transition Is Not a Major Modulating Factor in the Cytotoxic Response to Natural Products in Cancer Cell Lines
by: Baris Kucukkaraduman, et al.
Published: (2021-09-01)

Plasticity between Epithelial and Mesenchymal States Unlinks EMT from Metastasis-Enhancing Stem Cell Capacity
by: Evelyne Beerling, et al.
Published: (2016-03-01)

Epithelial-mesenchymal transition: Understanding the basic concept
by: Suresh Babu Ghanta, et al.
Published: (2012-01-01)

The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
by: Nele Loret, et al.
Published: (2019-06-01)

FOXC2 expression and epithelial–mesenchymal phenotypes are associated with castration resistance, metastasis and survival in prostate cancer
by: Astrid Børretzen, et al.
Published: (2019-10-01)

The ELF3 transcription factor is associated with an epithelial phenotype and represses epithelial-mesenchymal transition
by: Ayalur Raghu Subbalakshmi, et al.
Published: (2023-03-01)

Epithelial-mesenchymal transition
by: Kubik Joanna, et al.
Published: (2023-03-01)

Anti-Cancer Potential of Phytochemicals: The Regulation of the Epithelial-Mesenchymal Transition
by: Shuangyu Liu, et al.
Published: (2023-06-01)

Epithelial-mesenchymal transition in ovarian carcinoma
by: Ben eDavidson, et al.
Published: (2012-04-01)

RPLP1 promotes tumor metastasis and is associated with a poor prognosis in triple-negative breast cancer patients
by: Zhixian He, et al.
Published: (2018-10-01)

Hybrid Epithelial/Mesenchymal State in Cancer Metastasis: Clinical Significance and Regulatory Mechanisms
by: Tsai-Tsen Liao, et al.
Published: (2020-03-01)

Regulation of Epithelial-Mesenchymal Transitions by Alternative Splicing: Potential New Area for Cancer Therapeutics
by: Ling Li, et al.
Published: (2023-10-01)

Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer
by: Pelin Balcik-Ercin, et al.
Published: (2021-10-01)

Understanding the relationship between circulating platelets and epithelial to mesenchymal transition – a step towards in discovering new epithelial ovarian cancer targeted therapies
by: Irina Balescu, et al.
Published: (2022-09-01)

Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin
by: H. J. Hugo, et al.
Published: (2017-07-01)

Progress of inhibiting epithelial-mesenchymal transition in retinal pigment epithelial cells
by: Duo Li, et al.
Published: (2018-12-01)

An Overview of Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Canine Tumors: How Far Have We Come?
by: Federico Armando, et al.
Published: (2022-12-01)

PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer
by: Ghaneya Al-Khadairi, et al.
Published: (2019-01-01)